Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director
|
MyMD Pharmaceuticals, Inc. (AKER)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/31/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
03/01/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
10/21/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
03/24/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
04/01/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
07/13/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
04/03/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
04/18/2017 |
10-K/A
| Annual Report for the period ended December 31, 2016 [amend] |
04/11/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
03/30/2016 |
10-K/A
| Annual Report for the period ended December 31, 2015 [amend] |
03/30/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
03/23/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
03/28/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
|
|